Acadia Healthcare Company, Inc. $ACHC Shares Bought by Invenomic Capital Management LP

Invenomic Capital Management LP boosted its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 41.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,936,396 shares of the company’s stock after purchasing an additional 568,796 shares during the period. Acadia Healthcare accounts for approximately 2.3% of Invenomic Capital Management LP’s portfolio, making the stock its 5th biggest position. Invenomic Capital Management LP owned about 2.10% of Acadia Healthcare worth $47,945,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Acadia Healthcare during the 1st quarter valued at about $1,600,000. Goldman Sachs Group Inc. raised its position in Acadia Healthcare by 21.1% during the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after acquiring an additional 121,444 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Acadia Healthcare by 8.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock worth $10,337,000 after purchasing an additional 27,207 shares during the last quarter. Allworth Financial LP lifted its stake in shares of Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after purchasing an additional 1,177 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its position in Acadia Healthcare by 26.9% during the second quarter. PNC Financial Services Group Inc. now owns 8,466 shares of the company’s stock worth $192,000 after buying an additional 1,794 shares during the last quarter.

Analyst Ratings Changes

ACHC has been the subject of a number of analyst reports. Jefferies Financial Group cut Acadia Healthcare to a “hold” rating in a research report on Thursday, January 22nd. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. UBS Group lifted their price objective on Acadia Healthcare from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Leerink Partners increased their target price on Acadia Healthcare from $14.00 to $22.00 and gave the company a “market perform” rating in a research note on Thursday, February 26th. Finally, Cantor Fitzgerald set a $17.00 price target on Acadia Healthcare in a research report on Wednesday, December 3rd. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Acadia Healthcare currently has an average rating of “Hold” and a consensus target price of $21.15.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $23.52 on Monday. The firm has a market capitalization of $2.17 billion, a PE ratio of -1.93, a PEG ratio of 7.95 and a beta of 0.73. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 1.27. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $31.04. The business’s 50 day moving average is $16.80 and its 200-day moving average is $18.73.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. The business had revenue of $821.46 million during the quarter, compared to analyst estimates of $800.10 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.Acadia Healthcare’s revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.64 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.